Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Average Rating of “Buy” from Brokerages
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) has earned a consensus rating of “Buy” from the six analysts that are covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year price objective […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) has earned a consensus rating of “Buy” from the six analysts that are covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year price objective […]
